Molecular analysis of Candida albicans isolates from clinical specimens

Mycopathologia

Volumn 169, Issue 4, 2010, Pages 261-267

  Gurbuz, Melahat ^a   Kaleli, Ilknur ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

25S; Candida albicans; Candida dubliniensis; Genotyping; Invasiveness

Indexed keywords

FUNGAL DNA; PRIMER DNA; RIBOSOME DNA; RIBOSOME RNA; RNA, RIBOSOMAL, 25S;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLASSIFICATION; DNA FINGERPRINTING; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY; POLYMERASE CHAIN REACTION;

CANDIDA ALBICANS; CANDIDIASIS; DNA FINGERPRINTING; DNA PRIMERS; DNA, FUNGAL; DNA, RIBOSOMAL; GENOTYPE; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RNA, RIBOSOMAL;

CANDIDA ALBICANS; CANDIDA DUBLINIENSIS;

EID: 77952673427     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-009-9263-z     Document Type: Article

References (36)

1. Sandhu GS, Cline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol. 1995; 33: 2913-9.
2. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007; 20: 133-63.
3. Richardson M, Lass-Flörl C. Changing epidemiology of systemic fungal infections. Clin Microbial Infect. 2008; 14(Suppl 4): 5-24.
4. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol. 2007; 45: 321-46.
5. Tamura M, Watanabe K, Mikami Y, Yazawa K, Nishimura K. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. J Clin Microbiol. 2001; 39: 4309-15.
6. Vrioni G, Bernard M. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. J Infect. 2001; 42: 50-6.
7. McCullough MJ, Clemons KV, Stevens DA. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol. 1999; 37: 417-21.
8. Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY antimicrobial surveillance program (2003). J Clin Microbiol. 2006; 44: 1782-7.
9. Warren NG, Hazen KC. Candida, Cryptococcus, and other yeasts of medical importance. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999. p. 1184-99.
10. Coleman DC, Rinaldi MG, Haynes KA, Rex JH, Summerbell RC, Anaissie EJ, et al. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med Mycol. 1998; 36(Suppl. 1): 156-65.
11. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida species from HIV infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother. 1995; 35: 103-14.
12. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother. 1995; 39: 1-8.
13. Nucci M, Colombo AL. Emergence of resistant Candida in neutropenic patients. Braz J Infect Dis. 2002; 6: 124-8.
14. Khan ZU, Mustafa AS. Detection of Candida species by polymerase chain reaction (PCR) in blood samples of experimentally infected mice and patients with suspected candidemia. Microbiol Res. 2001; 156: 95-102.
15. De Baere T, Claeys G, Swinne D, Massonet C, Verschraegen G, Muylaert A, et al. Identification of cultured isolates of clinically important yeast species using fluorescent fragment length analysis of the amplified internally transcribed rRNA spacer 2 region. BMC Microbiol. 2002; 2: 21.
16. Pfaller MA. Epidemiology of fungal infections: the promise of molecular typing. Clin Infect Dis. 1995; 20: 1535-9.
17. Bretange S, Costa JM, Besmond C, Casique R, Calderone R. Microsatellite polymorphism in the promoter sequence of the elongation factor 3 gene of Candida albicans as the basis for a typing system. J Clin Microbiol. 1997; 35: 1777-80.
18. Soll DR. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev. 2000; 13: 332-70.
19. Espinel-Ingroff A, Vazquez JA, Boikov D, Pfaller MA. Evaluation of DNA-based typing procedures for strain categorization of Candida spp. Diag Microbiol Infect Dis. 1999; 33: 231-9.
20. Mc Cullough MJ, Clemons KV, Mc Cusker JH, Stevens DA. Intergenic transcribed spacer PCR ribotyping for differentiation of Saccharomyces species and interspecific hybrids. J Clin Microbiol. 1998; 36: 1035-8.
21. Maleska R, Clark-Walker GD. Yeasts have a four-fold variation in ribosomal DNA copy number. Yeast. 1993; 9: 53-8.
22. Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol. 1998; 36: 329-34.
23. Sullivan DJ, Moran G, Donnelly S, Gee S, Pinjon E, McCartan B, et al. Candida dubliniensis: an update. Rev Iberoamer Micol. 1999; 16: 72-6.
24. Millar BC, Moore JE, Xu J, Walker MJ, Hedderwick S, McMullan R. Genotypic subgrouping of Candida albicans and Candida dubliniensis by 25S intron analysis. Lett Appl Microbiol. 2002; 35: 102-6.
25. Kumar CPG, Hanafy AM, Katsu M, Mikami Y, Menon T. Moleculer analysis and susceptibility profiling of Candida albicans isolated from immunocompromised patients in South India. Mycopathologia. 2006; 161: 153-9.
26. Tay ST, Chai HC, Na SL, Ng KP, Soo-Hoo TS. Molecular subtyping of clinical isolates of Candida albicans and identification of Candida dubliniensis in Malaysia. Mycopathologia. 2005; 159: 325-9.
27. Karahan ZC, Güriz H, Aǧi{dotless}rbaşli{dotless} H, Balaban N, Göçmen JS, Aysev D, et al. Genotype distribution of Candida albicans isolates by 25S intron analysis with regard to invasiveness. Mycoses. 2004; 47: 465-9.
28. Millar BC, Xu J, McMullan R, Walker MJ, Hedderwick S, Moore JE. Frequency and distribution of group 1 intron genotypes of Candida albicans colonising critically ill patients. Br J Biomed Sci. 2005; 62: 24-7.
29. Qi QG, Hu T, Zhou XT. Frequency, species and molecular characterization of oral Candida in hosts of different age in China. J Oral Pathol Med. 2005; 34: 352-6.
30. Karahan ZC, Akar N. Subtypes of genotype A Candida albicans isolates determined by restriction endonuclease and sequence analyses. Microbiol Res. 2005; 160: 361-6.
31. McCullough MJ, Clemons KV, Stevens DA. Molecular epidemiology of the global and temporal diversity of Candida albicans. Clin Infect Dis. 1999; 29: 1220-5.
32. Koyuncu E, Dolapçi{dotless} I, Karahan C, Tekeli A, Akan OA. Genotype distribution of Candida albicans strains isolated from invasive and noninvasive samples. Ankara Unv Ti{dotless}p Fak Mecm. 2007; 60: 53-6 (Article in Turkish).
33. Luu NL, Cowen LE, Sirjusingh C, Kohn LM, Anderson JB. Multilocus genotyping indicates that the ability to invade the bloodstream is widespread among Candida albicans isolates. J Clin Microbiol. 2001; 39: 1657-60.
34. Dalle F, Franco N, Lopez J, Vagner O, Caillot D, Chavanet P, et al. Comparative genotyping of Candida albicans bloodstream and nonbloodstream isolates at a polymorphic microsatellite locus. J Clin Microbiol. 2000; 38: 4554-9.
35. Lunel FV, Liciardello L, Stefani S, Verbrugh HA, Melchers WJG, Meis JFGM, et al. Lack of consistent short sequence repeat polymorphisms in genetically homologous colonizing and invasive Candida albicans strains. J Bacteriol. 1998; 180: 3771-8.
36. Mercure S, Montplaisir S, Lemay G. Correlation between the presence of a self-splicing intron in the 25S rDNA of C. albicans and strains susceptibility to 5-fluorocytosine. Nucleic Acids Res. 1993; 21: 6020-7.